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Most TPSs (terpene synthases) contain plasticity residues
that are responsible for diversified terpene products and
functional evolution, which provide a potential for improving
catalytic efficiency. Artemisinin, a sesquiterpene lactone from
Artemisia annua L., is widely used for malaria treatment
and progress has been made in engineering the production
of artemisinin or its precursors. In the present paper, we
report a new sesquiterpene synthase from A. annua, AaBOS
(A. annua α-bisabolol synthase), which has high sequence
identity with AaADS (A. annua amorpha-4,11-diene synthase),
a key enzyme in artemisinin biosynthesis. Comparative analysis
of the two enzymes by domain-swapping and structure-based
mutagenesis led to the identification of several plasticity
residues, whose alteration changed the product profile of AaBOS
to include γ -humulene as the major product. To elucidate
the underlying mechanisms, we solved the crystal structures
of AaBOS and a γ -humulene-producing AaBOS mutant (termed
AaBOS-M2). Among the plasticity residues, position 399, located
in the substrate-binding pocket, is crucial for both enzymes. In
AaBOS, substitution of threonine for leucine (AaBOSL339T)
is required for γ -humulene production; whereas in AaADS,
replacing the threonine residue with serine (AaADST399S) resulted
in a substantial increase in the activity of amorpha-4,11-diene
production, probably as a result of accelerated product release.
The present study demonstrates that substitution of plasticity
residues has potential for improving catalytic efficiency of the
enzyme.
Key words: Artemisia annua, catalytic efficiency, domain
swapping, plasticity residue, product profile, terpene synthase.
INTRODUCTION
Terpenoids constitute a large and structurally diverse class of
natural products. The plant terpenoids not only contribute to plant
adaptation to the environment [1], but also provide a valuable
source of lead compounds for medicine [2,3]. For instance,
artemisinin, an endoperoxide sesquiterpene lactone isolated from
the traditional herb Artemisia annua L., is an effective component
against malaria [4,5]. Each individual terpene compound is often
present in small quantities in the native organism, and chemical
syntheses of these compounds are usually difficult owing to
their complex structure, hindering their usage by humans. These
problems prompted investigation of alternative methodologies to
obtain valuable terpenoids, among which synthetic biology is
considered particularly promising [6].
TPSs (terpene synthases) catalyse the conversion of allylic
prenyldiphosphate building blocks, including GPP (geranyl
diphosphate; C10), FPP (farnesyl diphosphate; C15) and GGPP
(geranylgeranyl diphosphate; C20), into different classes of
terpenes [1,7,8]. They are important in directing isoprenoid flux
into a specific group of terpenes as they operate at metabolic
branch points and often compete with other enzymes for an
allylic prenyldiphosphate pool. For example, FPP is the precursor
to many cellular molecules such as squalene, dolichols and the
cofactor haem, in addition to various sesquiterpenes formed by
sesquiterpene synthases. However, TPSs show lower catalytic
efficiency than most of the central metabolic enzymes [9]. The
average kcat value of the former is 2.5 s− 1, whereas the latter
is 79 s− 1, approximately 30-fold greater than the former [9],
suggesting that TPSs are far from optimized by natural selection
in terms of catalytic efficiency. TPSs hold the key to high yield
of desired products in metabolic engineering, thus understanding
the catalytic mechanisms of these enzymes is of great importance.
TPSs have complicated catalytic mechanisms. They contain
large active sites that allow the binding and folding of
the substrate, the generation and stabilization of high-energy
carbocations, and the acidic/basic catalysis to dictate specific
skeletal and metabolic fates [7,10]. Finally, the reaction is ended
by product release, which is often a rate-limiting step [11].
It has been proposed that the secondary metabolic enzymes
tend to develop catalytic elasticity during evolution [12], which
allows emergence of new enzymes with expanded substrate
scope and multiple new products. Within and around the
active site of a TPS, certain ‘special’ amino acid residues
(plasticity residues) are mainly responsible for the catalytic
elasticity [13,14], and alterations to a small number of them can
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6-fluorofarnesyl diphosphate; FHP, farnesylhydroxyphosphonate; FPP, farnesyl diphosphate; NtEAS, Nicotiana tobacum 5-epi-aristolochene synthase;
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profoundly shift the product specificity [8,15,16]. This plasticity
allows host organisms to drastically change the spectrum of
terpenoid production at the expense of only a few amino acid
substitutions in TPSs, thus these enzymes are considered hot spots
in evolution [15,17]. Gene duplication and tandem duplication
events have provided a genetic reservoir for the biosynthetic
diversity of terpenes, as the extra copies of TPS genes are
available for mutation and evolution without compromising the
original activity [18,19]. The important role of plasticity residues
in catalytic specificity suggests that they should exert influence on
certain steps of the complex catalytic reaction. This is supported
by the reports that changed product profiles could be accompanied
by altered reaction velocities as the result of substitutions of a few
amino acids of enzymes [15,20,21]; an isoleucine-to-threonine
change, for example, switched an Arabidopsis thaliana kaurene
synthase to a pimaradiene synthase with a 4-fold decrease in
catalytic efficiency [16]. However, the involvement of plasticity
residues of a TPS in catalytic activity have not been studied
in detail, and their potential for improving catalytic efficiency
remains unexplored.
Domain swapping between related enzymes and site-directed
mutagenesis have been frequently used to identify functional
regions and/or residues of TPSs [15–17,19,21,22]. In most cases,
domain swapping could lead to defining the minimum segment or
residues that mediate product specificity, but without a complete
change of products generated, thus suggesting participation of
other residues. A structure-based strategy has been developed in
recent years, in which comparison of three-dimensional structures
of TPSs allowed the identification of plasticity residues directly
or indirectly involved in the catalytic process [23]. On the basis of
the structure of NtEAS (Nicotiana tobacum 5-epi-aristolochene
synthase) [13], a reciprocal interconversion of catalytic specificit-
ies between NtEAS and Hyoscyamus muticus premnaspirodiene
synthase was achieved with substitutions of nine amino acids
[14]. Besides structural information, phylogenetic comparisons
are also important in guiding mutagenesis experiments [8].
A. annua harbours a wealth of terpenoids [24–29] and has a
long history of use in traditional Chinese medicine [30]. Enzymes
catalysing the first step of artemisinin biosynthesis [AaADS (A.
annua amorpha-4,11-diene synthase)] and subsequent reactions
[24,25,28,31–33], as well as regulatory factors [34] of the
artemisinin pathway have been reported. Despite the importance
of AaADS in artemisinin biosynthesis, at present the molecular
basis of its catalytic mechanism remains elusive, partly due to the
lack of a functionally similar enzyme in A. annua and structural
information of AaADS.
In the present paper, we report the characterization of a
novel sesquiterpene synthase from AaBOS (A. annua α-bisabolol
synthase), which displays a high sequence identity with AaADS.
Determination of the crystal structure of AaBOS, and domain-
swapping and site-directed mutagenesis experiments led to the
identification of residues, which we designated the BOS motif,
that are essential for product specificity in both enzymes.
Importantly, the T399S mutation in the BOS motif of AaADS
(AaADST399S) drastically increased catalytic efficiency of the
mutant enzyme.
MATERIALS AND METHODS
Materials
Seeds of A. annua cv. Qiute were surface-sterilized and ger-
minated in Murashige and Skoog medium. Seedlings (2 weeks
old) were transferred to soil and grown in a greenhouse at
25 ◦C under a light intensity of 150 μmol of photons · m− 2 · s− 1
with a 14-h-light/10-h-dark cycle. Tissues of 10-week-old
plants were used for gene expression analysis unless otherwise
indicated. Leaves close to inflorescences (approximately one-
third of the upper stem) were defined as young, and
leaves close to the basal part (one-third of the lower stem)
were defined as mature. Isolation of glandular trichomes
and cDNA library construction were performed according
to a previously published protocol [29]. Chemicals were
purchased from Sigma–Aldrich, and FHP (farnesylhydroxyphos-
phonate) was from Enzo Life Sciences. 2F-FPP (2-fluorofarnesyl
diphosphate) and 6F-FPP (6-fluorofarnesyl diphosphate) were
synthesized as described previously [35,36]. ESTs (expressed
sequence tags) were generated at the Shanghai Biochip Company.
Gene isolation, expression and sequence analysis
Total RNA was extracted using TRIzol® reagent (Invitrogen).
Total RNA (1 μg) was reverse-transcribed using the RNA
PCR [AMV (avian myoblastosis virus)] kit (TaKaRa), followed
by cDNA synthesis and gene expression analysis. Full-
length cDNAs were isolated by 5′- and 3′-rapid amplification
of cDNA ends using the Pfu enzyme (Promega). qRT-
PCR (quantitative real-time PCR) was performed with SYBR
Green PCR Mastermix (TaKaRa) on a Mastercycler® ep
RealPlex2 (Eppendorf) cycler with A. anuua actin (EU531837)
as a reference. The expression levels of genes were determined as
described previously [37], and the relative expression of each
gene was compared with the expression level in root which was
set to 1. Nucleotide and amino acid sequence alignments were
performed using ClustalW [38]. Secondary structure predictions
were performed by ESPript [39]. Primers used in this investigation
are listed in Supplementary Table S1 (at http://www.biochemj.
org/bj/451/bj4510417add.htm).
Mutagenesis, bacterial expression and enzyme assay
Mutagenesis was generated by PCR using an overlap extension
strategy [40] with the respective primers (Supplementary Table
S1). The ORFs (open reading frames) of AaBOS, AaADS and
the mutant cDNAs were amplified using Pfu DNA polymerase,
followed by insertion into pET32a. Escherichia coli BL21(DE3)
cells were used for protein production. Recombinant proteins
were purified with Ni-NTA (Ni2 + -nitrilotriacetate) spin columns
(Qiagen). The protein concentration was determined using the
Bradford method with BSA as a standard.
Assays of sesquiterpene synthases were performed in a volume
of 500 μl containing 20 μg of protein, 25 mM Hepes (pH 7.0),
5 mM MgCl2, 5 mM DTT (dithiothreitol) and 40 μM FPP [41],
and conducted at 37 ◦C for 1 h unless otherwise indicated.
The reaction mixture was extracted with 400 μl of hexane and
subjected to analysis by GC–MS (Agilent 6890 Series GC System
coupled to an Agilent 5973 Network Mass Selective Detector),
with the following temperature programme: initial temperature
of 80 ◦C (2-min hold), increase to 250 ◦C at 10 ◦C/min, and ramp
to 280 ◦C at 20 ◦C/min (3-min hold). Products were identified
by comparison with authentic standards (Sigma–Aldrich), and
NIST (National Institute of Standards and Technology) and Wiley
libraries. For quantitative analysis, nerolidol was added as an
internal standard during hexane extraction of the enzyme reaction
mixture.
The kinetic parameters of AaBOS, AaADS and the mutant
enzymes were determined according to previously published
methods [8]. Briefly, the purified enzyme of 3 μg was added to
each assay mixture containing various concentrations of FPP in
the range 3–100 μM. The reaction was allowed to proceed for 5 or
c© The Authors Journal compilation c© 2013 Biochemical Society
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Table 1 Statistics of diffraction data and structure refinement
Numbers in parentheses represent the highest resolution shell.
Parameter AaBOS AaBOS-M2
Data collection
Wavelength (A˚) 1.0000 1.0000
Space group P21 P21
Resolution (A˚) 50.00–2.00 (2.07–2.00) 50.00–2.00 (2.07–2.00)
Cell parameters
a, b, c (A˚) 52.0, 77.3, 68.8 52.7, 77.1, 68.3
β (◦) 102.5 102.3
Observed reflections 131389 134078
Unique reflections [I/σ (I)>0] 35037 (3409) 36270 (3646)
Average redundancy 3.8 (3.7) 3.7 (3.8)
Average I/(I) 16.0 (2.9) 20.2 (7.4)
Completeness (%) 97.2 (94.7) 99.7 (99.6)
Rmerge (%) 8.7(52.3) 8.2 (40.8)
Refinement
Resolution (A˚) 50.00–2.00 50.00–2.00
Rwork/R free 0.181/0.223 0.175/0.230
Number of protein atoms 4286 4294
Number of water atoms 285 324
Average B factor of all atoms (A˚2) 26.9 38.9
Main chain 24.8 35.7
Side chain 28.6 42.1
Water 29.6 38.7
R.m.s.d.
Bond lengths (A˚) 0.007 0.008
Bond angles (◦) 0.998 1.033
Ramachandran plot (%)
Favoured 96.8 91.5
Allowed 3.2 8.5
10 min at 25 ◦C, stopped by the addition of 0.5 M EDTA (pH 8.0)
and products were extracted with 400 μl of hexane containing
10 ng/μl nerolidol as an internal standard, followed by GC–MS
analysis. The assays were performed in TIM (total ion monitoring)
mode. One unit of enzyme activity was defined as the amount of
enzyme required to produce 1 μmol of product per min under
the conditions stated above. Values were obtained with GraphPad
Prism 5 software fitting the Michaelis–Menten curve.
The optimal temperature was determined at a series of
temperatures ranging from 25 to 50 ◦C in 25 mM Hepes (pH 7.0),
and the optimal pH was determined at 25 ◦C in 50 mM Bis-
Tris buffer (pH 6.0–7.0), 50 mM Tris/HCl (pH 7.0–8.6) or 50 mM
glycine/NaOH (pH 8.6–10.6).
Crystallization, data collection and structure determination
Protein was concentrated to 6 mg/ml for crystal screening, and
the protein in 0.8 μl was mixed with an equal volume of reservoir
solution, and crystals were grown at 4 ◦C by the sitting-drop
vapour-diffusion method. Rod-like crystals appeared after 3 days
and grew to approximately 0.05 mm × 0.05 mm × 0.10 mm
in 2 weeks. The crystals used for data collection were grown in
0.1 M Hepes and 29% PEG [poly(ethylene) glycol] 3000 at
pH 7.8. The crystals were flash-frozen at 100 K and diffraction
data were collected to 2.0 Å (1 Å = 0.1 nm) at beamline BL17U at
the SSRF (Shanghai Synchrotron Radiation Facility). Data were
processed with HKL2000 [42] and belonged to the space group
P21. Additional processing was carried out using programs from
the CCP4 suite [43].
The structure of AaBOS was determined using the molecular
replacement method with PDB code 3M01 (NtEAS) [44] as
the search model. One protein molecule was found in each
asymmetric unit. Model building and refinement were carried
Figure 1 Expression levels of A. annua farnesyl diphosphate synthase
(AaFPS; AF112881), CYP71AV1 (DQ872632), AaADS and AaBOS in different
organs of the 10-week-old A. annua plants
The relative expression of each gene was compared with its expression level in roots which was
set to 1. Values are means +− S.D. for three technical replicates. INF, inflorescence; ML, mature
leaves; R, root; S, stem; YL, young leaves.
out using Coot [45] and Phenix [46]. The final model contained
residues 17–546, with residues 449–457 being disordered.
The structure of AaBOS-M2 (a γ -humulene-producing AaBOS
mutant) was solved using AaBOS as a model, and refinement
was conducted in a similar manner. Data collection and structure
refinement statistics are summarized in Table 1.
RESULTS AND DISCUSSION
Isolation and characterization of AaBOS
From a cDNA library of A. annua glandular trichomes, one
of the ESTs exhibited a high nucleotide sequence identity
(92%) with AaADS. The cDNA (GenBank® accession number
JQ717161) codes for a protein of 546 amino acids, the
same length as AaADS, with a calculated molecular mass of
63.8 kDa. The protein contains a typical DDxxD (DDIYD) motif
and an atypical NSE/DTE (NDLAGHKEE) motif common to
the sesquiterpene synthase family [7] (Supplementary Figure
S1 at http://www.biochemj.org/bj/451/bj4510417add.htm). qRT-
PCR showed that the highest expression level of this gene
was present in inflorescences. In mature leaves, the transcript
abundance was low but definite, whereas in young leaves, stems
and roots, the expression was barely detectable (Figure 1).
Interestingly, the artemisinin pathway genes of AaADS and
CYP71AV1 showed a similar enrichment of transcripts in
inflorescences, in agreement with previous reports [32,34].
To identify the activity of this putative sesquiterpene synthase,
we expressed it in E. coli and performed the enzyme assay
with FPP. GC-MS analysis of the assay extract revealed
a major product, α-bisabolol (Figure 2), which accounted
c© The Authors Journal compilation c© 2013 Biochemical Society
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Figure 2 GC–MS analysis of in vitro assay products of AaBOS
(A–C) Total ion chromatogram of assay products with proteins of the empty pET32a vector (A), the recombinant AaBOS (B) and the α-bisabolol authentic standard (C). The GC expansion shows
peaks of minor products: 2, trans-α-bisabolene; 3, β-bisabolene; 4, cis-γ -bisabolene; 5, β-sesquiphellandrene and 6, cis-α-bisabolene. (D and E) Mass spectra of the major product (peak 1) of
AaBOS (D) and of α-bisabolol authentic standard (E).
for 92.8% of the total products, hence the enzyme was
named AaBOS. Additionally, five minor sesquiterpenes were
detected, they were trans-α-bisabolene (1.1%), cis-γ -bisabolene
(2.4%), cis-α-bisabolene (1.2%), β-bisabolene (1.9%) and
β-sesquiphellandrene (0.51%) (Supplementary Figures S2
and S3 at http://www.biochemj.org/bj/451/bj4510417add.htm).
α-Bisabolene and β-bisabolene are among the reported compo-
nents of A. annua essential oil [30], and α-bisabolene and
β-sesquiphellandrene are also the minor products of AaADS
[28]. Kinetic analysis with FPP showed that AaBOS has a
Michaelis constant (Km) of 17.11 μM, kcat of 1.55 s− 1, a Vmax
of 4.64×10− 3 μM · s− 1 · mg− 1 and a specific constant (kcat/Km)
c© The Authors Journal compilation c© 2013 Biochemical Society
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Table 2 Kinetic parameters of AaBOS, AaADS and the AaADST399S mutant
using FPP as a substrate
Kinetic parameter AaBOS AaADS AaADST399S
K m (μM) 17.11 3.56 3.79
k cat (s− 1) 1.55 1.37 2.51
V max (μM · s− 1 · mg− 1) 4.64 × 10− 3 4.12 × 10− 3 7.53 × 10− 3
k cat/K m (μM− 1 · s− 1) 0.0905 0.385 0.662
value of 9.05×10− 2 μM− 1.s− 1, approximately 4-fold less active
than AaADS (Table 2).
The presence of by-products strongly suggests that α-bisabolol
is derived from the intermediate bisabolyl cation generated from
the E,Z-farnesyl cation through electrophilic 1,6-ring closure
(Scheme 1). AaBOS promotes water capture of the bisabolyl
cation to generate and release α-bisabolol, while deprotonation
from C-6, C-8 and C-14 yields trans-α-bisabolene (4), cis-γ -
bisabolene (1), cis-α-bisabolene (2) and β-bisabolene (3), and
β-sesquiphellandrene is most probably generated through 1,3-
hydride shift and subsequent proton-elimination at C-15.
Structure of AaBOS
To disclose the molecular mechanism of product
generation, AaBOS was crystallized and its structure solved to 2.0
Å. The final model contained residues 17–546; residues 449–457,
which are part of the H3 helix, were not visible in the structure
(Table 1). The structure was in apo form, with no metal ion
binding despite 2 mM Mg2 + being present during the purification
and crystallization steps. Co-crystallization of AaBOS with FPP,
2F-FPP, 6F-FPP and FHP, as well as soaking of the crystals
of apo-AaBOS with these ligands were attempted, but none of
the structures solved contained the above substrates. AaBOS
adopts a similar three-dimensional structure to that typically
found in plant sesquiterpene synthases: there are two compact
α-helical domains, the N-terminal domain and the C-terminal
catalytic domain (Figure 3A). Comparison of the AaBOS
structure with that of NtEAS showed r.m.s.d. (root mean square
deviation) values of 2.0 Å. The major differences are found in the
C-terminal domain; superimposition the structures of AaBOS and
NtEAS revealed that all of the helices (helix A to helix K) except
for helix I and the short α1 helix (connecting helix H and I) fit
very well. The axes of helix I and helix α1 rotate approximately
10◦ away from helix G around a hinge formed by the I–J loop
(Figure 3B). In AaBOS and NtEAS, the DDxxD motifs are in
helix D, but the NSE/DTE motif of NtEAS is replaced by NGE
and the segment is partially disordered in AaBOS, possibly
due to the absence of a bound substrate analogue and/or metal
ions. This observation suggests that the NGE motif plays a
subtle role in binding substrate and metal ions (Supplementary
Figure S1).
Identification of AaBOS regions involved in product specificity
AaBOS has a high amino acid sequence identity (82%) with
AaADS, and they may share the bisabolyl cation as common
carbocation intermediate (Scheme 1). The similarities in sequence
and mechanism suggest that a comparative analysis of the two
enzymes could reveal key residues for the activity of AaADS.
We applied a domain-swapping strategy to localize regions
related to the distinctive products of AaBOS and AaADS. The
proteins were divided into three fragments (I, II and III), an
initial set of chimaeric enzymes were constructed with reciprocal
Figure 3 The structure of AaBOS
(A) The overall structure of AaBOS as a cylinder cartoon. (B) Superimposition of AaBOS (green)
and NtEAS (grey) defines the active-site cavity with the substrate analogue 2F-FPP from NtEAS
(PDB code 3M01) shown as a golden stick. The side chains of Ile395, Asn398, Leu399, Val373 and
Leu381 in AaBOS are shown in magenta.
replacement of the corresponding fragments, and the resultant
activities were measured to localize fragments containing
the sites essential for activity. The active fragments were
further divided into sub-segments and were reciprocally
substituted until the minimum segment or residues mediating
product specificity were located. After three cycles, in which
fragments II and III were divided into sub-fragments II.1,
II.2, II.3, III.1 and III.2, and then II.3 into II.3.1 and II.3.2
(Figure 4 and Supplementary Figure S1), we generated mutant
AaBOS enzymes that produced an additional product, which was
identified as γ -humulene (Figure 4B and Supplementary Figure
S4 at http://www.biochemj.org/bj/451/bj4510417add.htm). Two
continuous fragments, II.3.1 (residues 343–381, located in helix
F) and II.3.2 (residues 392–399, located in helix G1) were found
to be indispensable (Figure 4C; CH9, CH12 and CH13) for
the formation of γ -humulene. Further site-directed mutagenesis
c© The Authors Journal compilation c© 2013 Biochemical Society
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Scheme 1 Proposed mechanisms for the conversion of FPP into sesquiterpene products catalysed by AaBOS, AaADS and their mutants
The scheme is based on previous studies of biosynthesis pathways of terpenes [7] and artemisinin [28,30,31,33] (the grey area denotes the artemisinin biosynthesis pathway). The numbered products
are: cis-γ -bisabolene (1), cis-α-bisabolene (2), β-bisabolene (3), trans-α-bisabolene (4).
led to the identification of several residues responsible for the
product specificity of AaBOS. A tetra-substituted mutant AaBOS-
M1 (V373N, I395V, N398I and L399T) and a penta-substituted
mutant AaBOS-M2 (V373N, L381A, I395V, N398I and L399T)
yielded 29.3 and 68.8% of γ -humulene respectively (Figure 4C).
Interestingly, γ -humulene is also a minor product of AaADS [28].
We propose that the formation of γ -humulene could be the result
of 1,11-ring closure resulting from attack of the C-10, C-11 π-
bond by C-1 in an anti-Markovnikov fashion (Scheme 1).
The BOS motif is closely related to the product specificity of AaBOS
Although the five residues identified in AaBOS-M2 may play
different roles in the production of γ -humulene, all γ -humulene-
producing mutants harboured the L399T substitution, suggesting
an important role for this substitution in determining product
specificity of AaBOS. In particular, although the CH12-M4 and
AaBOS-M2 mutants containing all five substitutions produced
γ -humulene, the CH12-M16 which lacked L339T did not
(Figure 4C), strongly supporting this notion. However, none of
the single-residue substitutions changed the product spectrum
of AaBOS (Supplementary Table S2 at http://www.biochemj.org/
bj/451/bj4510417add.htm), indicating a synergistic effect of these
residues. To examine the effect of these residues on product
specificity, we crystallized and solved the structure of AaBOS-
M2, which produced 68.8% of γ -humulene. The overall structure
of AaBOS-M2 is nearly identical with that of AaBOS, except for
a conformational change caused by a slight counter-clockwise
rotation of helix G1 and F as a rigid body towards the vertical axis
(Figure 5A). In the two structures, four of the above mentioned
residues, Val373, Ile395, Asn398 and Leu399, are proximal to each
other and constitute a motif, which we named the BOS motif.
Val373 from helix F is on one side of the BOS motif and Ile395,
Asn398 and Leu399 from helix G1 are on the other side. Residue 381,
located at the C-terminus of helix F, protrudes into the substrate-
binding pocket and away from the BOS motif (Figures 3B and 5).
Although the conformational change found in the AaBOS-M2
structure resulted in a minor volume change of the substrate-
binding pocket, alteration in the shape of the pocket is substantial.
This alteration may have caused the variation in folding of the
substrate. In combination with the observed indispensable role of
Thr399 in affecting product specificity of AaBOS, we postulated
that Thr399, probably the side-chain hydroxy group, is involved
in the 1,11-ring closure and production of the cis-humulyl cation
(Scheme 1). However, without the help of other mutations in
the BOS motif in altering the pocket shape, the hydroxy group
of Thr399 may be away from the functional position and could
not exert any effect in directing 1,11-ring closure, which
could explain why all of the single-residue substitutions failed
to change the product spectrum of AaBOS.
To confirm this finding, the four residues were further replaced
by the corresponding ones in AaFS (A. annua β-farnesene
synthase) (NVVT) [27] and AaGAS (A. annua germacrene
A synthase) (GNIT) [29] respectively. Both of the mutants
(AaBOS-M11 and AaBOS-M12) produced α-bisabolol, together
with γ -humulene as a minor product, accounting for
approximately 13.7 and 8.3% of the total products respectively
(Supplementary Table S2), again supporting the notion that the
BOS motif, composed of plasticity residues, plays an important
role in determining the product specificity of AaBOS.
The side chain of Ala381/Leu381 is located on the rim of exit or
entrance of the pocket (Figure 5B) and may exert an effect on
the release of product. The large size of the side chain of leucine
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Figure 4 Identification of plasticity residues
(A) Schematic diagram showing amino acid residues that are different between AaBOS and AaADS in fragment II.3. (B) Total ion chromatogram of products of the substituted mutant CH12-M4 of
AaBOS. Peaks of products: 1, α-bisabolol; 7, γ -humulene. (C) Schematic view of site-directed substitutions of AaBOS (left-hand panel) and the respective enzyme activities, showing the percentage
of γ -humulene in total products (right-hand panel).
Figure 5 The activity centre structures of AaBOS and AaBOS-M2
(A) Structure comparison of the BOS motif in AaBOS and AaBOS-M2. Helix F and helix G1 of AaBOS are shown in green, whereas those of AaBOS-M2 are in purple. Side chains constituting the BOS
motif and residue 381 are shown with green/golden sticks in AaBOS/AaBOS-M2. (B) Molecular surface representation shows the FPP-binding pocket and the side chain of Ala381/Leu381 located on
the rim of the exit or entrance.
may hinder the release of γ -humulene, but not α-bisabolol as α-
bisabolol is more linear and flexible than γ -humulene, whereas
alanine with a small side chain may have no bias towards these
two compounds. Thus the replacement of leucine with alanine
may relieve the bias and release more γ -humulene over α-
bisabolol. Indeed, AaBOS-M2 with an additional mutation of
L381A exhibited an approximate doubling in production of γ -
humulene compared with AaBOS-M1 in the assay (Figure 4C).
Role of Thr399 in AaADS catalytic efficiency
With the information on plasticity residues of AaBOS at hand,
site-directed mutagenesis was performed on the BOS motif region
of AaADS to explore the catalytic role of the corresponding
residues in AaADS. Although most of the mutants were inactive
or less active than the wild-type enzyme, one of the single
mutants, T399L (AaADST399L), exhibited an altered product
specificity (Figure 6A, and Supplementary Table S3 at http://
www.biochemj.org/bj/451/bj4510417add.htm). Besides the pro-
duct amorpha-4,11-diene, AaADST399L produced a high amount of
amorpha-4,7(11)-diene and low amounts of β-sesquiphellandrene
and zingiberene (Figure 6A and Supplementary Figure S3). The
formation of amorpha-4,7(11)-diene might be the result of proton
extraction at C-10, instead of C-12/C-13 as that of amorpha-
4,11-diene, and nearly equal yields of amorpha-4,11-diene and
amorpha-4,7(11)-diene suggests the loss of regioselectivity of
deprotonation. A premature quenching of the C-1 bisabolyl cation
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Figure 6 Characterization of AaADS and mutants
GC–MS analysis of replacing of AaADS Thr399 with acidic, alkaline and neutral amino acids (A) and comparison of AaADS and AaADST399S activities under different temperature (B) and pH
(C) conditions. (A) Total ion chromatograms of products of AaADS and mutant enzymes as indicated. The GC expansion shows peaks produced by AaADST399L: 8, amorpha-4,11-diene; 9,
amorpha-4,7(11)-diene; 10, zingiberene; 11, β-sesquiphellandrene. (B and C) The relative activity of the wild-type and the mutant enzymes, shown as a percentage of the maximum activity of the
wild-type AaADS for amorpha-4,11-diene.
generates the products of β-sesquiphellandrene and zingiberene
(Scheme 1).
Position 399 in AaADS, important for catalytic specificity,
was further replaced with acidic, alkaline and neutral amino
acids. Replacing with aspartic acid (AaADST399D) or arginine
(AaADST399R) resulted in loss of catalytic activity, whereas a
neutral residue substitution (AaADST399A or AaADST399N) led to
product distributions similar to that of AaADST399L (Figure 6A).
Strikingly, when the threonine residue was replaced with the
similar, but smaller, amino acid serine (AaADST399S), the yield of
amorpha-4,11-diene was increased by 70%, and its proportion
also increased from 92.0 to 93.9% of the total products
(Figure 6A). The kinetic parameters of AaADST399S were analysed
with steady-state measurements. Compared with the wild-type,
AaADST399S showed higher turnover rate of FPP and higher
activity at pH 7.0. kcat is increased by approximately 83%, and
the kcat/Km value is increased by 71.7% (Table 2). Clearly,
AaADST399S is a more efficient enzyme than the wild-type. Under
different temperature and pH conditions, AaADST399S showed
varied performances compared with the wild-type enzyme. In the
temperature range 25–40 ◦C, AaADST399S had a higher activity
than AaADS; when the temperature was raised to above 45 ◦C,
both enzymes rapidly lost activity (Figure 6B). Both AaADS and
AaADST399S have two optimal pH values under acidic (pH 6.5)
and alkaline (pH 9.8 and pH 10.5) conditions; mutation of
threonine to serine shifted the alkaline optimal pH of the enzyme
from 10.5 to 9.8. Under conditions of pH 5.5–9.8, AaADST399S
was generally more active than the wild-type emzyme, but at
exceptionally higher pH values, AaADST399S lost its activity more
rapidly (Figure 6C). These data indicate that the T339S mutation
greatly improved the enzymatic activity under a wide range of
temperature and pH conditions.
Considering the location of residue 399 in the substrate-binding
pocket in AaBOS, it is reasonable to assume that the presence
and absence of the hydroxy group in the side chain of amino
acid 399 contributes to the catalytic specificity in AaADS. The
hydroxy group of threonine might be involved in regioselective
deprotonation, as mutations of Thr399 with other amino acid
residues (except for serine which also has a hydroxy group)
generated an additional product arising from different ways of
proton loss at C-10. Thus the yield of amorpha-4,7(11)-diene
(Scheme 1) could be the result of the loss of regioselectivity
of deprotonation. Furthermore, this change of mechanism may
lead to the decrease in the efficiency of proton elimination and
the resultant accumulation of intermediates, which is supported
by the increased amount of by-products of β-sesquiphellandrene
and zingiberene. Notably, AaADS and its functionally normal
mutant AaADST399S, the aforementioned γ -humulene-producing
mutants of AaBOS, as well as AaFS and AaGAS, all contain
threonine/serine at position 399. Their hydroxy group side chains
could take part in catalytic processes. By contrast, AaBOS has a
neutral amino acid, leucine, which may not directly participate in
catalytic reactions. It is possible that the mutation of T399L of the
BOS motif resulted in neofunctionalization of an additional copy
of AaADS or its ancestral progenitor and gave rise to AaBOS
later during evolution. We searched 140 plant TPSs with known
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function, among which 120 have threonine/serine at position 399,
suggesting that it is highly, but not invariably, conserved with
the two alcoholic amino acids. We postulate that this position is
of wide-ranging importance for catalysis by plant TPSs. It is an
important finding that a single substitution (T399S) increased
the catalytic efficiency of AaADS. As the hydroxy group of
threonine/serine is likely to be involved in deprotonation, the
final step of the whole catalytic reaction, a change from threonine
to serine may favour the deprotonation process. Additionally, it
might influence the hydrophilic environment of the pocket from
which the final product is released. Compared with threonine,
serine has a more polar side chain affording a more hydrophilic
environment, thus the hydrophobic product may be released
more rapidly. Replacing the threonine residue with a similar,
but smaller, amino acid (serine) could maintain the catalytic
mechanism without a profound change of the product profile,
whereas previous research in plasticity residues has generally led
to change in mechanism and shifted product specificity.
Concluding remarks
TPSs tend to develop catalytic elasticity during evolution [12],
which is also the case in AaBOS and AaADS. AaBOS has a high
nucleotide sequence identity (92%) with and similar catalytic
mechanism to AaADS, implying that they are closely related
in evolution. This is shown by only a few residue changes for
divergence to occur from the ancestral enzyme. The findings of
the present study are in agreement with previous reports which
suggested that the new function of an existing enzyme is often the
result of a relatively low number of mutations [8,12,15,47].
The observation that TPSs tend to evolve new functions rather than
improving efficiency for currently recognized substrates supports
the proposed role in ecology, i.e. plant terpenoid profiles can
rapidly change in response to environmental influence. Moreover,
this malleable characteristic has allowed us to change a TPS with
a single threonine to serine mutation and profoundly increase its
catalytic efficiency.
At present, extraction of A. annua plants is still the major
source of artemisinin. Many efforts have been made to engineer
artemisinin-related production in both microbes and plants [6,48].
By introducing the mevalonate and artemisinin metabolic pathway
enzymes into E. coli or Saccharomyces cerevisiae, artemisinic
acid has been produced by fermentation [6,31]. Engineering
more efficient enzymes, such as the AaADST399S reported in the
present paper, is expected to further facilitate the synthetic biology
approach to artemisinin production. In addition, the natural
sesquiterpene alcohol α-bisabolol is widely used in the fragrance
and cosmetic industry owing to its anti-inflammatory, analgesic,
antibiotic and probably anticancer properties [49]. A recent report
demonstrated a novel biosynthetic alternative to D2 diesel fuel,
bisabolane, whose precursor bisabolene could be produced by
microbial engineering [50]. Through simple chemical reactions,
α-bisabolol also can yield the terpene-based biofuel bisabolane.
Cloning of α-bisabolol synthase opens up a new avenue to the
production of this sesquiterpene alcohol in a large scale via
metabolic engineering.
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Figure S1 Comparison of amino acid sequences of AaBOS with four plant sesquiterpene synthases
The alignment was generated by the program ClustalW and drawn with ESPript. Consensus amino acid residues are boxed in black, the secondary structure elements of AaBOS are shown above
the sequences, and the highly conserved metal cofactor-binding regions of the DDxxD motif and NSE/DTE motif are underlined. The catalytically important mutagenesis residues are indicated by
triangles, and the fragments (of AaBOS and AaADS) used in domain swapping are indicated by transverse lines. The sesquiterpene synthase sequences aligned comprise four from A. annua, AaBOS
(JQ717161), AaADS (CAB94691), AaFS (AAX39387) and AaGAS (ABE03980), and one from N. tabacum, NtEAS (Q40577).
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Figure S2 Mass spectra of the by-products of AaBOS
(A) Mass spectrum of peak 2 in Figure 2 of the main text. (B) Mass spectrum of trans-α-bisabolene [in the NIST (National Institute of Standards and Technology) library]. (C) Mass spectrum of
peak 4 in Figure 2 of the main text. (D) Mass spectrum of cis-γ -bisabolene (in the NIST library). (E) Mass spectrum of peak 6 in Figure 2 of the main text. (F) Mass spectrum of cis-α-bisabolene
(in the NIST library). (G) Mass spectrum of peak 3 in Figure 2 of the main text. (H) Mass spectrum of β-bisabolene (in the NIST library). Mass spectrum of peak 5 in Figure 2 of the main text and
β-sesquiphellandrene are shown in Figure S3.
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Figure S3 Mass spectra of the additional products formed by AaADS mutants
(A) Mass spectrum of peak 9 in Figure 6 of the main text. (B) Mass spectrum of amorpha-4,7(11)-diene (a gift from Professor Peter E. Brodelius). (C) Structure of amorpha-4,7(11)-diene. (D) Mass
spectrum of peak 10 in Figure 6 of the main text. (E) Mass spectrum of zingiberene (in the NIST library). (F) Structure of zingiberene. (G) Mass spectrum of peak 11 in Figure 6 of the main text.
(H) Mass spectrum of β-sesquiphellandrene (in the NIST library). (I) Structure of β-sesquiphellandrene (8).
Figure S4 Mass spectra of the additional product formed by AaBOSmutants
(A) Mass spectrum of the additional product (peak 7) in Figure 4 of the main text. Rt, retention
time. (B) The reported mass spectrum of γ -humulene [1].
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Table S1 Oligonucleotide primers used in the present study
AS, antisense; S, sense.
Primer name Sequence (5′→3′) Purpose
AaActin-RT-S CTTTGAACCCTAAGGCTAATC qRT-PCR
AaActin-RT-AS GGGCATACCCTTCGTAGATAG qRT-PCR
AaBOS-RT-S3 GATCTTGCGGGCCACAAGGAG qRT-PCR
AaBOS-RT-AS2 CAGAACATCCAGAAAATGTAC qRT-PCR
AaADS-SRT-S GATCTCATGACCCACAAGGCC qRT-PCR
AaADS-SRT-AS TTGAACTTCAAGAAACTGGCA qRT-PCR
AaFPS-S AGAAAGTCCTACATGAGAAC qRT-PCR
AaFPS-AS TGCCTCTTATCAGGA GAATG qRT-PCR
CYP71AV1-S CGGATGTTGTTCTTGCACCTTAT qRT-PCR
CYP71AV1-AS TTCAGCACTGTCTTTGAGCCTTA qRT-PCR
pETAaBOS-S TTTCCATGGCTATGTCTCTTACAGAAGAAAAACCTA Protein expression
pETAaBOS-AS-final TTTGGATCCTCATATACTCATAGGATAAACGAGT Protein expression
pETAaADS-S TTTCCATGGCTATGTCACTTACAGAAGAAAAACCTA Protein expression
pETAaADS-AS-final TTTGGATCCTCATATACTCATAGGATAAACGAGTAG Protein expression
AaBOS-DR-S1 CCCCTTTGGAAAAGGTTGCCAAG Domain swapping
AaBOS-DR-AS1 CTTGGCAACCTTTTCCAAAGGGG Domain swapping
AaBOS-DR-S2 TGAGGGACACATACCAACCACTG Domain swapping
AaBOS-DR-AS2 CAGTGGTTGGTATGTGTCCCTCA Domain swapping
AaBOS-DW-S1 GAGATAGAATTGTTGAATGCTAC Domain swapping
AaBOS-DW-AS1 GTAGCATTCAACAATTCTATCTC Domain swapping
AaBOS-DW-S2 CATGAAACCGATATACAAATTATTC Domain swapping
AaBOS-DW-AS2 GAATAATTTGTATATCGGTTTCATG Domain swapping
AaBOS-DW-S3 CCTGCTTACAACAACTTGTTATC Domain swapping
AaBOS-DW-AS3 GATAACAAGTTGTTGTAAGCAGG Domain swapping
AaBOS-DW-S4 GGAAAGATATAAACCGAGAGTACC Domain swapping
AaBOS-DW-AS4 GGTACTCTCGGTTTATATCTTTCC Domain swapping
AaBOS-L392H-S CCAACCACTGAAGAGCATGATTCAATTGCAGTCAAT Site-directed mutagenesis
AaBOS-L392H-AS ATTGACTGCAATTGAATCATGCTCTTCAGTGGTTGG Site-directed mutagenesis
AaBOS-M4-S1 TGAAGAGCTTGATTCAGTTGCAATCATTACTGGCGG Site-directed mutagenesis
AaBOS-M4-AS1 CCGCCAGTAATGATTGCAACTGAATCAAGCTCTTCA Site-directed mutagenesis
AaBOS-S394P-S CCAACCACTGAAGAGCTTGATCCAATTGCAGTCAAT Site-directed mutagenesis
AaBOS-S394P-AS GATCAAGCTCTTCAGTGGTTGGTATGTGTCC Site-directed mutagenesis
AaBOS-I395V-S CCACTGAAGAGCTTGATTCAGTTGCAGTCAATCTTG Site-directed mutagenesis
AaBOS-I395V-AS CTGAATCAAGCTCTTCAGTGGTTGGTATGTG Site-directed mutagenesis
AaBOS-A396V-S TGAAGAGCTTGATTCAATTGTAGTCAATCTTGGCGG Site-directed mutagenesis
AaBOS-A396V-AS ACAATTGAATCAAGCTCTTCAGTGGTTGGTA Site-directed mutagenesis
AaBOS-V397I-S AAGAGCTTGATTCAATTGCAATCAATCTTGGCGGTG Site-directed mutagenesis
AaBOS-V397I-AS TTGCAATTGAATCAAGCTCTTCAGTGGTTGG Site-directed mutagenesis
AaBOS-N398I-S GCTTGATTCAATTGCAGTCATTCTTGGCGGTGCTAA Site-directed mutagenesis
AaBOS-N398I-AS ATGACTGCAATTGAATCAAGCTCTTCAGTGG Site-directed mutagenesis
AaBOS-L399T-S TTGATTCAATTGCAGTCAATACTGGCGGTGCTAACCT Site-directed mutagenesis
AaBOS-L399T-AS GTATTGACTGCAATTGAATCAAGCTCTTCAGT Site-directed mutagenesis
AaBOS-397/9-AS GCACCGCCAGTATTGATTGCAATTGAATCAAGCTC Site-directed mutagenesis
AaBOS-398/9-S GAGCTTGATTCAATTGCAGTCATTACTGGCGGTGC Site-directed mutagenesis
AaBOS-398/9-AS GCACCGCCAGTAATGACTGCAATTGAATCAAGCTC Site-directed mutagenesis
AaBOS-395/7/8-S GAGCTTGATTCAGTTGCAATCATTCTTGGCGGTGC Site-directed mutagenesis
AaBOS-395/7/8-AS GCACCGCCAAGAATGATTGCAACTGAATCAAGCTC Site-directed mutagenesis
AaBOS-395/7/9-S GAGCTTGATTCAGTTGCAATCAATACTGGCGGTGC Site-directed mutagenesis
AaBOS-395/7/9-AS GCACCGCCAGTATTGATTGCAACTGAATCAAGCTC Site-directed mutagenesis
AaBOS-395/8/9-S GAGCTTGATTCAGTTGCAGTCATTACTGGCGGTGC Site-directed mutagenesis
AaBOS-395/8/9-AS GCACCGCCAGTAATGACTGCAACTGAATCAAGCTC Site-directed mutagenesis
AaBOS-397/8/9-S GAGCTTGATTCAATTGCAATCATTACTGGCGGTGC Site-directed mutagenesis
AaBOS-397/8/9-AS GCACCGCCAGTAATGATTGCAATTGAATCAAGCTC Site-directed mutagenesis
AaBOS-350-S GAAATGGAAGAATTTCTTGCAAAGGAG Site-directed mutagenesis
AaBOS-350-AS CTCCTTTGCAAGAAATTCTTCCATTTC Site-directed mutagenesis
AaBOS-356-S GCAAAGGAGGGAAGAACAAATATATTT Site-directed mutagenesis
AaBOS-356-AS AAATATATTTGTTCTTCCCTCCTTTGC Site-directed mutagenesis
AaBOS-358-S GGAGGGAAAAACAGATATATTTAACTG Site-directed mutagenesis
AaBOS-358-AS CAGTTAAATATATCTGTTTTTCCCTCC Site-directed mutagenesis
AaBOS-359-S GGGAAAAACAAATCTATTTAACTGTGG Site-directed mutagenesis
AaBOS-359-AS CCACAGTTAAATAGATTTGTTTTTCCC Site-directed mutagenesis
AaBOS-369-S GAATTTGTGAAAGAGTTTGTTAGAGTCC Site-directed mutagenesis
AaBOS-369-AS GGACTCTAACAAACTCTTTCACAAATTC Site-directed mutagenesis
AaBOS-373-S GATTTTGTTAGAAACCTGATGGTTGAAG Site-directed mutagenesis
AaBOS-373-AS CTTCAACCATCAGGTTTCTAACAAAATC Site-directed mutagenesis
AaBOS-379-S GATGGTTGAAGCAAAATGGTTAAATGAG Site-directed mutagenesis
AaBOS-379-AS CTCATTTAACCATTTTGCTTCAACCATC Site-directed mutagenesis
AaBOS-381-S GGTTGAAGCACAATGGGCAAATGAGGGACAC Site-directed mutagenesis
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Table S1 Continued
Primer name Sequence (5′→3′) Purpose
AaBOS-381-AS GTGTCCCTCATTTGCCCATTGTGCTTCAACC Site-directed mutagenesis
AaAaADS-373-AS TGGTTGGTATGTGTCCCTCATTTGCCCATTTTGCTTCAACCATCAGGACTCTAACAAAC Site-directed mutagenesis
AaADS-M3-S GGGACACATACCAACCACTGAAGAGCATGATCCAATTGTAATCAATCTTGGCGGTGCTA Site-directed mutagenesis
AaADS-373-S1 GAGTTTGTTAGAGTCCTGATGGTTG Site-directed mutagenesis
AaADS-373-AS1 CAACCATCAGGACTCTAACAAACTC Site-directed mutagenesis
AaADS-395-AS ATGATTACAATTGGATCATGCTC Site-directed mutagenesis
AaADS-398-AS CACCGCCAGTATTGATTACAACT Site-directed mutagenesis
AaADS-399-AS TAGCACCGCCAAGAATGATTACAAC Site-directed mutagenesis
AaADS-373/395-S GGGACACATACCAACCACTGAAGAGCATGATCCAATTGTAATCATTACTGGCGGTGCTA Site-directed mutagenesis
AaADS-373/398-S GGGACACATACCAACCACTGAAGAGCATGATCCAGTTGTAATCAATACTGGCGGTGCTA Site-directed mutagenesis
AaADS-373/399-S GGGACACATACCAACCACTGAAGAGCATGATCCAGTTGTAATCATTCTTGGCGGTGCTA Site-directed mutagenesis
AaADS-395/8-AS TAGCACCGCCAGTATTGATTACAATTGGATCATGCTC Site-directed mutagenesis
AaADS-395/9-AS TAGCACCGCCAAGAATGATTACAATTGGATCATGCTC Site-directed mutagenesis
AaADS-398/9-AS TAGCACCGCCAAGATTGATTACAAC Site-directed mutagenesis
AaADS-373/395/398-S GGGACACATACCAACCACTGAAGAGCATGATCCAATTGTAATCAATACTGGCGGTGCTA Site-directed mutagenesis
AaADS-373/395/399-S GGGACACATACCAACCACTGAAGAGCATGATCCAATTGTAATCATTCTTGGCGGTGCTA Site-directed mutagenesis
AaADS-373/398/399-S GGGACACATACCAACCACTGAAGAGCATGATCCAGTTGTAATCAATCTTGGCGGTGCTA Site-directed mutagenesis
AaADS-395/8/9-S GAGCATGATCCAATTGTAATCAATCTTGGCGGTGCTA Site-directed mutagenesis
AaADS-395/8/9-AS TAGCACCGCCAAGATTGATTACAATTGGATCATGCTC Site-directed mutagenesis
AaADS-T399S-S GTTGTAATCATTAGTGGCGGTGCTA Site-directed mutagenesis
AaADS-T399S-AS TAGCACCGCCACTAATGATTACAAC Site-directed mutagenesis
AaADS-T399A-S GTTGTAATCATTGCTGGCGGTGCTA Site-directed mutagenesis
AaADS-T399A-AS TAGCACCGCCAGCAATGATTACAAC Site-directed mutagenesis
AaADS-T399N-S GTTGTAATCATTAATGGCGGTGCTA Site-directed mutagenesis
AaADS-T399N-AS TAGCACCGCCATTAATGATTACAAC Site-directed mutagenesis
AaADS-T399D-S GTTGTAATCATTGATGGCGGTGCTA Site-directed mutagenesis
AaADS-T399D-AS TAGCACCGCCATCAATGATTACAAC Site-directed mutagenesis
AaADS-T399R-S GTTGTAATCATTCGTGGCGGTGCTA Site-directed mutagenesis
AaADS-T399R-AS TAGCACCGCCACGAATGATTACAAC Site-directed mutagenesis
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Table S2 Substitutions of AaBOS and products of the respective enzymes
A circle indicates that this product is generated by this mutant. No entry indicates no substituted positions or product not detected.
II.3.1 II.3.2 Products
Substitution name 350 356 358 359 369 373 379 381 392 394 395 396 397 398 399 α-Bisabolol γ -Humulene
CH9 I350F K356R N358D I359L D369E V373N Q379K L381A L392H S394P I395V A396V V397I N398I L399T  
CH12 I350F K356R N358D I359L D369E V373N Q379K L381A 
CH13 L392H S394P I395V A396V V397I N398I L399T
CH12-M8 I350F K356R N358D I359L D369E V373N Q379K L381A L392H 
CH12-M9 I350F K356R N358D I359L D369E V373N Q379K L381A S394P 
CH12-M10 I350F K356R N358D I359L D369E V373N Q379K L381A I395V 
CH12-M11 I350F K356R N358D I359L D369E V373N Q379K L381A A396V 
CH12-M12 I350F K356R N358D I359L D369E V373N Q379K L381A V397I 
CH12-M13 I350F K356R N358D I359L D369E V373N Q379K L381A N398I 
CH12-M14 I350F K356R N358D I359L D369E V373N Q379K L381A L399T 
CH12-M15 I350F K356R N358D I359L D369E V373N Q379K L381A I395V V397I 
CH12-M16 I350F K356R N358D I359L D369E V373N Q379K L381A I395V N398I 
CH12-M2 I350F K356R N358D I359L D369E V373N Q379K L381A I395V L399T  
CH12-M17 I350F K356R N358D I359L D369E V373N Q379K L381A V397I N398I 
CH12-M18 I350F K356R N358D I359L D369E V373N Q379K L381A V397I L399T 
CH12-M3 I350F K356R N358D I359L D369E V373N Q379K L381A N398I L399T  
CH12-M5 I350F K356R N358D I359L D369E V373N Q379K L381A I395V V397I N398I 
CH12-M6 I350F K356R N358D I359L D369E V373N Q379K L381A I395V V397I L399T  
CH12-M4 I350F K356R N358D I359L D369E V373N Q379K L381A I395V N398I L399T  
CH12-M7 I350F K356R N358D I359L D369E V373N Q379K L381A V397I N398I L399T  
CH12-M1 I350F K356R N358D I359L D369E V373N Q379K L381A I395V V397I N398I L399T  
AaBOS-M3 I395V N398I L399T 
AaBOS-M4 I350F I395V N398I L399T 
AaBOS-M5 K356R I395V N398I L399T 
AaBOS-M6 N358D I395V N398I L399T 
AaBOS-M7 I359L I395V N398I L399T 
AaBOS-M8 D369E I395V N398I L399T 
AaBOS-M1 V373N I395V N398I L399T  
AaBOS-M9 Q379K I395V N398I L399T 
AaBOS-M10 L381A I395V N398I L399T
AaBOS-M2 V373N L381A I395V N398I L399T  
CH13-M1 V373N L392H S394P I395V A396V V397I N398I L399T  
CH13-M2 V373N L381A L392H S394P I395V A396V V397I N398I L399T  
AaBOS-M11 V373N I395V N398V L399T  
AaBOS-M12 V373G I395N N398I L399T  
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Table S3 Substitutions of AaADS and products of the respective enzymes
A circle indicates that this product is generated by this mutant. No entry indicates no substituted
positions or product not detected. The numbered products denote: (2) amorpha-4,11-diene, (8)
β-sesquiphellandrene, (11) zingiberene and (10) amorpha-4,7(11)-diene.
Substitutions Products
Substitution name 373 395 398 399 2 8, 10, 11
AaADS-M1 N373V 
AaADS-M2 V395I 
AaADS-M3 I398N 
AaADS-M4 T399L  
AaADS-M5 N373V V395I
AaADS-M6 N373V I398N 
AaADS-M7 N373V T399L
AaADS-M8 V395I I398N 
AaADS-M9 V395I T399L  
AaADS-M10 I398N T399L  
AaADS-M11 N373V V395I I398N 
AaADS-M12 N373V V395I T399L
AaADS-M13 N373V I398N T399L
AaADS-M14 V395I I398N T399L  
AaADS-M15 N373V V395I I398N T399L
AaADST399D T399D
AaADST399R T399R
AaADST399A T399A  
AaADST399N T399N  
AaADST399S T399S 
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